OxiGene (OXGN)
Create an Alert
3.05
-0.07 -2.24%
NASDAQ
Jun 19, 8:00PM
BATS Real time
Currency in USD
OxiGene Cash from Operations Quarterly:
-1.894M for March 31, 2013OxiGene Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -1.894M |
| Dec. 31, 2012 | -1.397M |
| Sept. 30, 2012 | -2.169M |
| June 30, 2012 | -2.472M |
| March 31, 2012 | -2.297M |
| Dec. 31, 2011 | -2.807M |
| Sept. 30, 2011 | -2.439M |
| June 30, 2011 | -2.953M |
| March 31, 2011 | -3.585M |
| Dec. 31, 2010 | -2.484M |
| Sept. 30, 2010 | -4.535M |
| June 30, 2010 | -6.815M |
| March 31, 2010 | -6.593M |
| Dec. 31, 2009 | -7.912M |
| Sept. 30, 2009 | -7.843M |
| June 30, 2009 | -5.99M |
| March 31, 2009 | -6.924M |
| Dec. 31, 2008 | -5.412M |
| Sept. 30, 2008 | -6.929M |
| June 30, 2008 | -5.763M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
OXGN Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| Anika Therapeutics | 6.069M |
| Bioline Rx | -5.283M |
| Repligen Corporation | 3.595M |
OXGN Cash from Operations Quarterly Rankings
| Overall |
59th percentile 6825 of 16782 |
| Sector |
56th percentile 613 of 1410 in Healthcare |
| Industry |
63rd percentile 165 of 454 in Biotechnology |
OXGN Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -7.912M | Dec 2009 |
| Maximum | -1.397M | Dec 2012 |
| Average | -4.461M |
